Where is ViaCyte headquartered?

ViaCyte is located in San Diego, CA.

Who invested in ViaCyte?

ViaCyte has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ViaCyte?

ViaCyte closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

viacyte.com

ViaCyte

ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.

Business Model:

Revenue: $25M

Employees: 51-200

ViaCyte was acquired by Vertex Pharmaceuticals.
The acquisition happend on 2022-07-11.
Details of the transaction were not public

Acquirer

Vertex Pharmaceuticals

General Information

Geographic Data

Address: 5580 Morehouse Drive

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

series d

Raised Last:

$0

Raised Total:

$221M

Social

Facebook

Twitter

Crunchbase

Metrics

2,258,022Website Global Rank

8,451Website Monthly Traffic

Twitter Followers

Description

ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.

Contact Phone:
+18582070500

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2007	Series C		$0	Asset Management Ventures (AMV) Johnson &a; Johnson Development Corporation Pacific Horizon Ventures Sanderling Ventures Asset Management Ventures (AMV) Johnson &a; Johnson Development Corporation Pacific Horizon Ventures Sanderling Ventures
8/2014	Venture Round	1	$20M	Johnson &a; Johnson Innovation Johnson &a; Johnson Innovation
4/2018	Grant		-
5/2017	Venture Round		$0	JDRF (The Juvenile Diabetes Research Foundation) W.L. Gore &a; Associates Asset Management Partners JDRF (The Juvenile Diabetes Research Foundation) W.L. Gore &a; Associates Asset Management Partners
7/2016	Grant		$3.9M
4/2021	Series D		$45M	Adage Capital Partners Invus Group Asymmetry Ventures Artis Ventures Bain Capital Life Sciences TPG Capital RA Capital Management Sanderling Ventures
4/2018	Grant	1	-	National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Diabetes and Digestive and Kidney Diseases
9/2018	Convertible Note	1	$10M	W.L. Gore &a; Associates W.L. Gore &a; Associates W.L. Gore &a; Associates W.L. Gore &a; Associates
3/2020	Series D		$0	Bain Capital Life Sciences RA Capital Management Sanderling Ventures TPG Capital Asia Bain Capital Life Sciences RA Capital Management Sanderling Ventures TPG Capital Asia
4/2021	Series D	1	-	Asymmetry Ventures Asymmetry Ventures
12/2017	Grant	1	$1.4M	California Institute for Regenerative Medicine California Institute for Regenerative Medicine
9/2014	Grant	1	$16.6M	California Institute for Regenerative Medicine
5/2000	Series B		-
8/2014	Series C		$5.4M
11/2018	Series D		$0	Bain Capital Life Sciences TPG RA Capital Management Sanderling Ventures Bain Capital Life Sciences Bain Capital Life Sciences TPG RA Capital Management Sanderling Ventures Bain Capital Life Sciences
7/2013	Series C	2	$10.6M	Sanderling Ventures Johnson &a; Johnson Development Corporation Sanderling Ventures Johnson &a; Johnson Development Corporation
5/2006	Venture Round		$0	Asset Management Ventures (AMV) BD Venture DFJ Portage Ventures Headland Ventures Johnson &a; Johnson Development Corporation Pacific Horizon Ventures Sanderling Ventures The Vertical Group Asset Management Ventures (AMV) BD Venture DFJ Portage Ventures Headland Ventures Johnson &a; Johnson Development Corporation Pacific Horizon Ventures Sanderling Ventures The Vertical Group
3/2020	Series D	4	$32.6M	Bain Capital Life Sciences TPG Capital RA Capital Management Sanderling Ventures Bain Capital Life Sciences RA Capital Management Sanderling Ventures TPG Capital Asia
11/2018	Series D	4	$80M	Bain Capital Life Sciences RA Capital Management TPG Capital Management Sanderling Ventures Bain Capital Life Sciences TPG RA Capital Management Sanderling Ventures Bain Capital Life Sciences
4/2018	Grant		-	National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Diabetes and Digestive and Kidney Diseases
5/2017	Equity	3	$10M	Asset Management Partners W.L. Gore & Associates, Inc JDRF
4/2021	Series D	1	-	Asymmetry Ventures Asymmetry Ventures
4/2018	Grant	1	-	National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Diabetes and Digestive and Kidney Diseases

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details